Tuesday, October 7, 2014

Experimental Ebola Drug Puts Its Maker, Chimerix, Back in the Spotlight

After the company drew negative publicity in March for denying a drug to a child, its stock jumped as that drug has shown promise in treating Ebola.


via NYT > Health http://ift.tt/1uZ8WqC








via All Health and Fitness http://ift.tt/1vRD6J2
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)